The effect of the COVID-19 pandemic on the mental health of patients with rheumatic diseases
Main Authors: | Hiba Ramdani, Othman Moueqqit, Abdelilah Lahmar, Jucier Gonçalves Júnior, Estelita Lima Cândido, Samuel Katsuyuki Shinjo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1007101/full |
Similar Items
-
Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
by: Mariangela Manfredi, et al.
Published: (2023-04-01) -
The Attitude of Egyptian Patients with Autoimmune and Rheumatic Diseases towards Telemedicine
by: Samar Tharwat, et al.
Published: (2023-09-01) -
Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
by: Rosaria Talarico, et al.
Published: (2023-03-01) -
Editorial: Molecular markers in rheumatic diseases and their comorbidities
by: Monica Vazquez-Del Mercado, et al.
Published: (2023-09-01) -
Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review
by: Florina Buleu, et al.
Published: (2019-06-01)